GlassScriptPhysician profile
Leela Lavasani
NPI 1083810493
$43,844.42
in general payments reported to CMS, 2019-2025
31 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $1,042 · 2021: $1,892 · 2022: $2,821 · 2023: $15K · 2024: $21K · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $6,333 · Honoraria: $6,000 · Travel and Lodging: $4,038 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,128.00 |
| Food and Beverage | $6,333.26 |
| Honoraria | $6,000.00 |
| Travel and Lodging | $4,038.24 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $39,339.50 | 2019-2025 | Inspire |
| Genzyme Corporation | $994.26 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $816.78 | 2021-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $514.59 | 2019-2024 | Fasenra |
| Glaxosmithkline, LLC. | $357.91 | 2020-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $244.76 | 2019-2024 | |
| Intersect Ent, INC. | $148.44 | 2019 | |
| Acera Surgical, INC. | $146.57 | 2024 | Restrata Wound Matrix |
| Kaleo, INC. | $132.75 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $127.99 | 2021-2023 | |
| Optinose US, INC. | $111.39 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $99.64 | 2021-2025 | Keytruda, Belsomra |
| Medtronic, INC. | $95.96 | 2024-2025 | Stealthstation S8 Platform, Propel |
| Organogenesis INC. | $88.54 | 2024-2025 | Affinity, Via Matrix, Puraply Wound Matrix |
| Xoran Technologies LLC | $88.33 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $87.81 | 2019-2023 | Xolair |
| Mimedx Group, INC. | $58.49 | 2025 | |
| Phadia US INC. | $51.45 | 2019-2023 | Immunocap |
| Hikma Pharmaceuticals USA | $46.12 | 2023-2025 | Ryaltris |
| Acclarent, INC | $42.99 | 2023 | Relieva Spinplus |
| Davol INC. | $40.42 | 2024 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $26.46 | 2025 | |
| Ambu INC. | $25.62 | 2021-2022 | |
| Checkpoint Surgical, INC | $24.17 | 2022 | |
| Stimlabs LLC | $22.80 | 2025 | Allacor P |
| Kerecis Limited | $21.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Focal Therapeutics, INC. | $21.28 | 2019 | |
| Stryker Corporation | $19.52 | 2022 | |
| Atos Medical INC | $17.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.21 | 2022 | |
| Olympus America INC. | $15.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leela Lavasani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.